Candida albicans

CANDIDA ALBICANS ORAL HUMAN PRESCRIPTION DRUG

Candida albicans is an FDA drug label for the active ingredient CANDIDA ALBICANS manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231115.

Generic name
CANDIDA ALBICANS
Manufacturer
Boiron
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Dosage form
N/A
NDC
0220-6413
Application
N/A
Label effective
20231115

Active ingredients

Candida albicans 8X (**contains 0.443 mg of the active ingredient per pellet)

Indications & Usage

Rx Only*

Dosage & Administration

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

Contraindications

Not available.

Warnings

Not available.

Adverse Reactions

Not available.

More products with the same ingredient

CANDIDA ALBICANS

CAN ALBEX 30X

Seroyal USA View label

CANDIDA ALB

BioActive Nutritional, Inc. View label

Can Albex 500X

Seroyal USA View label

Candida

BioActive Nutritional, Inc. View label

Candida Alb

BioActive Nutritional, Inc. View label

Candida Alb

BioActive Nutritional, Inc. View label

Candida Albicans 30C

Energique, Inc. View label

Candida Albicans Phenolic

Energique, Inc. View label